Composition. Each 250 mg hard capsule contains:
Active ingredient: tauroursodeoxycholic acid dihydrate 250 mg Excipients: microcrystalline cellulose, lactose, maize starch, magnesium stearate
Hard capsule composition: gelatine Ph. Eur., titanium dioxide, Erytrosine, Indigotine, Quinoline Yellow.
Therapeutic indications . Quali-quantitative alterations of the bilegenetic function, including forms caused by cholesterol-oversatured bile, to fight the formation of cholesterolic gallstones or to realize conditions able to dissolve radiotransparent gallstones if already formed. Particularly cholecystic gallstones in operating cholecyst and remaining and recurrent gallstones in choledoch after operations on biliary ways.
Therapy of chronic cholestatic liver diseases (primary biliary cirrhosis, primary sclerosant cholangitis, cholestasis associated to cystic fibrosis, intra-hepatic familial pediatric cholestasis, chronic liver diseases). Liver dyspepsia in patients with or without cholecystectomy.
Pharmaceutical form. hard capsules oral use.
Italian MA holder. BRUSCHETTINI S.r.l. – Genova (Italy)
Packaging: 20 hard capsules of 250 mg each.